Delivery Order SPE2DB20D1109-SPE2DB22FP40B

Award Date 6/8/22
Potential Completion Date 6/9/22
Potential Value $6.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a range of pharmaceutical products and medical supplies. The contract, valued at $16,754.91, covers the delivery of Cosentyx 300 mg dose-2 pens and has an ultimate completion date of April 11, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $19,651.29 firm-fixed-price delivery order is for Cosentyx 300 mg dose-2 pens. The order has an ultimate completion date of April 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Cosentyx 300 mg dose-2 Pen/SML to the Defense Logistics Agency (DLA). The $10,927.75 firm-fixed-price delivery order has a completion date of May 19, 2023 and is not set aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,963.70 firm fixed-price delivery order is for the pharmaceutical product Cosentyx 300 mg dose. The contract has an ultimate completion date of May 16, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx 300 mg dose-2 pens. The contract has a ceiling value of $24,034.24 and an ultimate completion date of September 28, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,122.28, is for the delivery of Cosentyx 300 mg dose-2 pens, a specialty medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx 300 mg dose-2 pens. The firm-fixed-price delivery order, valued at $8,958.78, has a completion date of June 6, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order with a Firm Fixed Price of $47,126.46 for the supply of Cosentyx 300 mg dose-2 pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, on February 8, 2022, with a completion date of February 9, 2022. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $2,986.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx 150 mg/ml pen injections. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,418.43 firm fixed-price delivery order is for the supply of Cosentyx 300 mg dose-2 pen, a specialty pharmaceutical medication. The contract has an ultimate completion date of May 9, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB22FP40B
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx 300 mg dose-2 pens. The $6,726.84 firm fixed-price contract has a completion date of June 9, 2022 and is not designated as a set-aside.

Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical commodities.

Generated 2/27/25, 12:41 PM